ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis

Journal of the International AIDS Society

Volumn 15, Issue 2, 2012, Pages

  Jurado, Javier Oscar ^a   Pasquinelli, Virginia ^a   Alvarez, Ivana Belén ^a   Martínez, Gustavo Javier ^b   Laufer, Natalia ^c,d   Sued, Omar ^c,d   Cahn, Pedro ^c,d   Musella, Rosa María ^a   Abbate, Eduardo ^a   Salomón, Horacio ^a   Quiroga, María Florencia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF TEXAS   (United States)

^c HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^d Huesped Foundation   (Argentina)

Author keywords

AIDS; Cytokines; Human; ICOS; PD 1; SLAM; T cells; Tuberculosis

Indexed keywords

CD150 ANTIGEN; GAMMA INTERFERON; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 10; PROGRAMMED DEATH 1 RECEPTOR; CELL SURFACE RECEPTOR; CYTOKINE; ICOS PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DYSREGULATION; IMMUNE RESPONSE; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; GENE EXPRESSION PROFILING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; SECRETION (PROCESS);

ANTIGENS, CD; CELL PROLIFERATION; CYTOKINES; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 84867459038     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.15.2.17428     Document Type: Article

References (30)

1. WHO. Global tuberculosis control - surveillance, planning, financing. WHO Report 2008 WHO/HTM/TB/2008393. Geneva, Switzerland: WHO; 2008.
2. Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol. 2002;32:1605-13.
3. Hertoghe T, Wajja A, Ntambi L, Okwera A, Aziz MA, Hirsch C, et al. T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol. 2000;122:350-7.
4. Quiroga MF, Pasquinelli V, Martinez GJ, Jurado JO, Zorrilla LC, Musella RM, et al. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol. 2006;176:5965-74.
5. Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, Abbate E, et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol. 2008;181:116-25.
6. Pasquinelli V, Quiroga MF, Martinez GJ, Zorrilla LC, Musella RM, Bracco MM, et al. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis. J Immunol. 2004;172:1177-85.
7. Loke P, Allison JP. Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells. Arthritis Res Ther. 2004;6:208-14.
8. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8:239-45.
9. Kaufmann DE, Walker BD. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection. Curr Opin HIV AIDS. 2008;3:362-7.
10. Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients. Int J Tuberc Lung Dis. 1998;2:317-23.
11. Uppal SS, Tewari SC, Verma S, Dhot PS. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Cytometry B Clin Cytom. 2004;61:20-6.
12. Spellberg B, Edwards JE Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76-102.
13. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771-7.
14. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis. 2007;7:428-38.
15. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest. 1994;94:2435-42.
16. Bal AM, Lakhashe SK, Thakar MR, Tripathy SP, Paranjape RS. Dysregulation of proinflammatory and regulatory cytokines in HIV infected persons with active tuberculosis. Cytokine. 2005;30:275-81.
17. de la Barrera S, Aleman M, Musella R, Schierloh P, Pasquinelli V, Garcia V, et al. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin Exp Immunol. 2004;138:128-38.
18. D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, et al. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol. 2007;179: 1979-87.
19. Zhou X, Kubo M, Nishitsuji H, Kurihara K, Ikeda T, Ohashi T, et al. Inducible-costimulator-mediated suppression of human immunodeficiency virus type 1 replication in CD4(+) T lymphocytes. Virology. 2004;325:252-63.
20. Veillette A. SLAM-family receptors: immune regulators with or without SAP-family adaptors. Cold Spring Harb Perspect Biol. 2010;2:a002469.
21. Kroczek RA, Mages HW, Hutloff A. Emerging paradigms of T-cell costimulation. Curr Opin Immunol. 2004;16:321-7.
22. Muthumani K, Choo AY, Shedlock DJ, Laddy DJ, Sundaram SG, Hirao L, et al. Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism. J Virol. 2008;82:11536-44.
23. Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA. 2008;105:19851-6.
24. Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomao R, Kallas EG. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol. 2002;128:149-54.
25. Shebl FM, Yu K, Landgren O, Goedert JJ, Rabkin CS. Increased levels of circulating cytokines with HIV-related immunosuppression. AIDS Res Hum Retroviruses. 2011; doi:10.1089/aid.2011.0144. (ahead of print).
26. Nixon DE, Landay AL. Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS. 2010;5:498-503.
27. Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, et al. Are CD4 + CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? Arthritis Res Ther. 2009;11:R153.
28. Imami N, Hardy G, Pires A, Burton C, Pido-Lopez J, Mela C, et al. Immune reconstitution in HIV-1-infected patients. Curr Opin Investig Drugs. 2002;3:1138-45.
29. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881-8.
30. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001;19:93-129.